Moderna Will Likely Miss Booster Deadline—Pfizer Only Shot Expected For Sept. Rollout

Pfizer is still on track, a source familiar with the review process told Forbes.

Read the full post on Forbes - Healthcare

Graison Dangor, Forbes Staff